ORGCAR19 / Orgenesis 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ORGCAR19 / Orgenesis
OREA, NCT05131373: Safety, Tolerability, and Immunogenicity of ORI-A-ce001 for the Treatment of Acne Vulgaris

Completed
1
38
Europe
ORG101 - Experimental 1, ORG101PL - Placebo 1
Sanofi Pasteur, a Sanofi Company
Acne Vulgaris, Acne
11/23
11/23

Download Options